Cargando…

Establishing pathological cut-offs for lateral ventricular volume expansion rates

BACKGROUND: A percent brain volume change (PBVC) cut-off of −0.4% per year has been proposed to distinguish between pathological and physiological changes in multiple sclerosis (MS). Unfortunately, standardized PBVC measurement is not always feasible on scans acquired outside research studies or aca...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dwyer, Michael G., Hagemeier, Jesper, Bergsland, Niels, Horakova, Dana, Korn, Jonathan R., Khan, Nasreen, Uher, Tomas, Medin, Jennie, Silva, Diego, Vaneckova, Manuela, Havrdova, Eva Kubala, Zivadinov, Robert
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2018
Materias:	Regular Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5842310/ https://www.ncbi.nlm.nih.gov/pubmed/29527505 http://dx.doi.org/10.1016/j.nicl.2018.02.009

Ejemplares similares

Evolution of Brain Volume Loss Rates in Early Stages of Multiple Sclerosis
por: Uher, Tomas, et al.
Publicado: (2021)

Gray matter atrophy patterns in multiple sclerosis: A 10-year source-based morphometry study
por: Bergsland, Niels, et al.
Publicado: (2017)

MRI correlates of disability progression in patients with CIS over 48 months
por: Uher, Tomas, et al.
Publicado: (2014)

Neurological software tool for reliable atrophy measurement (NeuroSTREAM) of the lateral ventricles on clinical-quality T2-FLAIR MRI scans in multiple sclerosis
por: Dwyer, Michael G., et al.
Publicado: (2017)

Natalizumab Induces Changes of Cerebrospinal Fluid Measures in Multiple Sclerosis
por: Ganapathy Subramanian, Ranjani, et al.
Publicado: (2021)

Bimonthly Evolution of Cortical Atrophy in Early Relapsing-Remitting Multiple Sclerosis over 2 Years: A Longitudinal Study
por: Zivadinov, Robert, et al.
Publicado: (2013)

Monitoring of radiologic disease activity by serum neurofilaments in MS
por: Uher, Tomas, et al.
Publicado: (2020)

Cognitive clinico‐radiological paradox in early stages of multiple sclerosis
por: Uher, Tomas, et al.
Publicado: (2017)

An Observational Study to Assess Brain MRI Change and Disease Progression in Multiple Sclerosis Clinical Practice—The MS‐MRIUS Study
por: Zivadinov, Robert, et al.
Publicado: (2016)

Decreasing brain iron in multiple sclerosis: The difference between concentration and content in iron MRI
por: Schweser, Ferdinand, et al.
Publicado: (2020)

Additive Effect of Spinal Cord Volume, Diffuse and Focal Cord Pathology on Disability in Multiple Sclerosis
por: Andelova, Michaela, et al.
Publicado: (2019)

Iron-related gene variants and brain iron in multiple sclerosis and healthy individuals
por: Hagemeier, Jesper, et al.
Publicado: (2017)

Isolated Cognitive Decline in Neurologically Stable Patients with Multiple Sclerosis
por: Motyl, Jiri, et al.
Publicado: (2021)

Periventricular gradient of T(1) tissue alterations in multiple sclerosis
por: Vaneckova, Manuela, et al.
Publicado: (2022)

Environmental Factors Associated with Disease Progression after the First Demyelinating Event: Results from the Multi-Center SET Study
por: Horakova, Dana, et al.
Publicado: (2013)

Volumetric MRI Markers and Predictors of Disease Activity in Early Multiple Sclerosis: A Longitudinal Cohort Study
por: Kalincik, Tomas, et al.
Publicado: (2012)

Clinical feasibility of longitudinal lateral ventricular volume measurements on T2-FLAIR across MRI scanner changes
por: Jakimovski, Dejan, et al.
Publicado: (2021)

Changes of deep gray matter magnetic susceptibility over 2 years in multiple sclerosis and healthy control brain
por: Hagemeier, Jesper, et al.
Publicado: (2017)

Effect of Teriflunomide and Dimethyl Fumarate on Cortical Atrophy and Leptomeningeal Inflammation in Multiple Sclerosis: A Retrospective, Observational, Case-Control Pilot Study
por: Zivadinov, Robert, et al.
Publicado: (2019)

Brainstem lesions are associated with diffuse spinal cord involvement in early multiple sclerosis
por: Andelova, Michaela, et al.
Publicado: (2022)

Cortical and Deep Gray Matter Perfusion Associations With Physical and Cognitive Performance in Multiple Sclerosis Patients
por: Jakimovski, Dejan, et al.
Publicado: (2020)

Peripheral blood lymphocytes immunophenotyping predicts disease activity in clinically isolated syndrome patients
por: Posová, Helena, et al.
Publicado: (2017)

Assessing ‘No Evidence of Disease Activity’ Status in Patients with Relapsing-Remitting Multiple Sclerosis Receiving Fingolimod in Routine Clinical Practice: A Retrospective Analysis of the Multiple Sclerosis Clinical and Magnetic Resonance Imaging Outcomes in the USA (MS-MRIUS) Study
por: Weinstock-Guttman, Bianca, et al.
Publicado: (2017)

Oxidative Stress Markers in Cerebrospinal Fluid of Newly Diagnosed Multiple Sclerosis Patients and Their Link to Iron Deposition and Atrophy
por: Burgetova, Andrea, et al.
Publicado: (2022)

Serum neurofilament light chain levels associations with gray matter pathology: a 5‐year longitudinal study
por: Jakimovski, Dejan, et al.
Publicado: (2019)

Diagnostic delay of multiple sclerosis: prevalence, determinants and consequences
por: Uher, Tomas, et al.
Publicado: (2023)

Measuring Aqueduct of Sylvius Cerebrospinal Fluid Flow in Multiple Sclerosis Using Different Software
por: Laganà, Maria Marcella, et al.
Publicado: (2021)

Retinal Blood Vessel Analysis Using Optical Coherence Tomography (OCT) in Multiple Sclerosis
por: Young, Nicholas, et al.
Publicado: (2023)

Longitudinal analysis of cerebral aqueduct flow measures: multiple sclerosis flow changes driven by brain atrophy
por: Jakimovski, Dejan, et al.
Publicado: (2020)

Neuroimaging Correlates of Patient-Reported Outcomes in Multiple Sclerosis
por: Jakimovski, Dejan, et al.
Publicado: (2023)

CSF Markers of Oxidative Stress Are Associated with Brain Atrophy and Iron Accumulation in a 2-Year Longitudinal Cohort of Early MS
por: Burgetova, Andrea, et al.
Publicado: (2023)

Establishing pathological cut-offs of brain atrophy rates in multiple sclerosis
por: De Stefano, Nicola, et al.
Publicado: (2016)

Serum neurofilament light chain and optical coherence tomography measures in MS: A longitudinal study
por: Tavazzi, Eleonora, et al.
Publicado: (2020)

Slowing of brain atrophy with teriflunomide and delayed conversion to clinically definite MS
por: Zivadinov, Robert, et al.
Publicado: (2020)

Increased contrast enhancing lesion activity in relapsing–remitting multiple sclerosis migraine patients()
por: Graziano, Elliot, et al.
Publicado: (2015)

Internal Jugular Vein Cross-Sectional Area Enlargement Is Associated with Aging in Healthy Individuals
por: Magnano, Christopher, et al.
Publicado: (2016)

Serum Neurofilament Light Chain Levels are Associated with Lower Thalamic Perfusion in Multiple Sclerosis
por: Jakimovski, Dejan, et al.
Publicado: (2020)

Validating atlas-based lesion disconnectomics in multiple sclerosis: A retrospective multi-centric study
por: Ravano, Veronica, et al.
Publicado: (2021)

Reliable measurements of brain atrophy in individual patients with multiple sclerosis
por: Smeets, Dirk, et al.
Publicado: (2016)

Deep Gray Matter Iron Content in Neuromyelitis Optica and Multiple Sclerosis
por: Pudlac, Adam, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_fe0niqse8bq3uqvldavlg6nain